Hpr6 (heme-1 domain protein) regulates the susceptibility of cancer cells to chemotherapeutic drugs

Journal of Pharmacology and Experimental Therapeutics

Volumn 316, Issue 1, 2006, Pages 448-455

  Crudden, Gerard ^a   Chitti, Rachel E ^a   Craven, Rolf J ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; DOXORUBICIN; HEME; HEME 1 DOMAIN PROTEIN 6; PROTEIN; UNCLASSIFIED DRUG;

ADENOVIRUS; ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; YEAST;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; MEMBRANE PROTEINS; NEOPLASMS; PLASMIDS; PROTEIN BINDING; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; VIRUSES;

EID: 29244483674     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.094631     Document Type: Article

References (29)

1. Anderson RG (2003) Joe Goldstein and Mike Brown: from cholesterol homeostasis to new paradigms in membrane biology. Trends Cell Biol 13:534-539.
2. Chabner BA, Ryan DP, Paz-Ares L, Garcia-Carbonero R, and Calabresi P (2001) Antineoplastic agents, in Goodman and Gilman's the Pharmacological Basis of Therapeutics (Hardman JG and Limbard LE eds), pp 1389-1459, McGraw-Hill, New York.
3. Crudden G, Loesel R, and Craven RJ (2005) Overexpression of the cytochrome P450 activator Hpr6 (heme-1 domain protein/human progesterone receptor) in tumors. Tumour Biol 26:142-146.
4. 5 reductase. Genomics 83:425-438.
5. Difilippantonio S, Chen Y, Pietas A, Schluns K, Pacyna-Gengelbach M, Deutschmann N, Padilla-Nash HM, Ried T, and Petersen I (2003) Gene expression profiles in human non-small and small-cell lung cancers. Eur J Cancer 39:1936-1947.
6. Falkenstein E, Meyer C, Eisen C, Scriba PC, and Wehling M (1996) Full-length cDNA sequence of a progesterone membrane-binding protein from porcine vascular smooth muscle cells. Biochem Biophys Res Commun 229:86-89.
7. Fan S, Wang JA, Yuan RQ, Rockwell S, Andres J, Zlatapolskiy A, Goldberg ID, and Rosen EM (1998) Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents. Oncogene 17:131-141.
8. Gao M, Fan S, Goldberg ID, Laterra J, Kitsis RN, and Rosen EM (2001) Hepatocyte growth factor/scatter factor blocks the mitochondrial pathway of apoptosis signaling in breast cancer cells. J Biol Chem 276:47257-47265.
9. Gerdes D, Wehling M, Leube B, and Falkenstein E (1998) Cloning and tissue expression of two putative steroid membrane receptors. Biol Chem 379:907-911.
10. Hand RA and Craven RJ (2003) Hpr6.6 protein mediates cell death from oxidative damage in MCF-7 human breast cancer cells. J Cell Biochem 90:534-547.
11. Hand RA, Jia N, Bard M, and Craven RJ (2003) Saccharomyces cerevisiae Dap1p, a novel DNA damage response protein related to the mammalian membrane-associated progesterone receptor. Eukaryot Cell 2:306-317.
12. Irby RB, Malek RL, Bloom G, Tsai J, Letwin N, Frank BC, Verratti K, Yeatman TJ, and Lee NH (2005) Iterative microarray and RNA interference-based interrogation of the SRC-induced invasive phenotype. Cancer Res 65:1814-1821.
13. Kage K, Tsukahara S, Sugiyama T, Asada S, Ishikawa E, Tsuruo T, and Sugimoto Y (2002) Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization. Int J Cancer 97:626-630.
14. Kim JW, Ye Q, Forgues M, Chen Y, Budhu A, Sime J, Hofseth LJ, Kaul R, and Wang XW (2004) Cancer-associated molecular signature in the tissue samples of patients with cirrhosis. Hepatology 39:518-527.
15. Laird SM, Vinson GP, and Whitehouse BJ (1988) Monoclonal antibodies against rat adrenocortical cell antigens. Acta Endocrinol (Copenh) 119:420-426.
16. Le Roy C and Wrana JL (2005) Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat Rev Mol Cell Biol 6:112-126.
17. Longley DB and Johnston PG (2005) Molecular mechanisms of drug resistance. J Pathol 205:275-292.
18. Mallory JC, Crudden G, Johnson BL, Mo C, Pierson CA, Bard M, and Craven RJ (2005a) Dap1p, a heme-binding protein that regulates the cytochrome P450 protein Erg11p/Cyp51p in Saccharomyces cerevisiae. Mol Cell Biol 25:1669-1679.
19. Mallory JC, Crudden G, Oliva A, Saunders C, Stromberg A, and Craven RJ (2005b) A novel group of genes regulate susceptibility to anti-neoplastic drugs in highly tumorigenic breast cancer cells. Mol Pharmacol 68:1748-1757.
20. Meyer C, Schmid R, Schmieding K, Falkenstein E, and Wehling M (1998) Characterization of high affinity progesterone-binding membrane proteins by antipeptide antiserum. Steroids 63:111-116.
21. Mifsud W and Bateman A (2002) Membrane-bound progesterone receptors contain a cytochrome b5-like ligand-binding domain. Genome Biol 3:RESEARCH0068.
22. Min L, Takemori H, Nonaka Y, Katoh Y, Doi J, Horike N, Osamu H, Raza FS, Vinson GP, and Okamoto M (2004) Characterization of the adrenal-specific antigen IZA (inner zone antigen) and its role in the steroidogenesis. Mol Cell Endocrinol 215:143-148.
23. Raza FS, Takemori H, Tojo H, Okamoto M, and Vinson GP (2001) Identification of the rat adrenal zona fasciculata/reticularis specific protein, inner zone antigen (IZAg), as the putative membrane progesterone receptor. Eur J Biochem 268:2141-2147.
24. Rishi V, Gal J, Krylov D, Fridriksson J, Boysen MS, Mandrup S, and Vinson C (2004) SREBP-1 dimerization specificity maps to both the helix-loop-helix and leucine zipper domains: use of a dominant negative. J Biol Chem 279:11863-11874.
25. Selmin O, Lucier GW, Clark GC, Tritscher AM, Vanden Heuvel JP, Gastel JA, Walker NJ, Sutter TR, and Bell DA (1996) Isolation and characterization of a novel gene induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Carcinogenesis 17:2609-2615.
26. Suchanek M, Radzikowska A, and Thiele C (2005) Photo-leucine and photo-methionine allow identification of protein-protein interactions in living cells. Nat Methods 2:261-267.
27. Yang T, Espenshade PJ, Wright ME, Yabe D, Gong Y, Aebersold R, Goldstein JL, and Brown MS (2002) Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 110:489-500.
28. Yang XH, Hand RA, Livasy CA, Cance WG, and Craven RJ (2003) Overexpression of the receptor tyrosine kinase Tie-1 intracellular domain in breast cancer. Tumour Biol 24:61-69.
29. Zhu L, Tran T, Rukstalis JM, Sun P, Damsz B, and Konieczny SF (2004) Inhibition of Mist1 homodimer formation induces pancreatic acinar-to-ductal metaplasia. Mol Cell Biol 24:2673-2681.